Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Publication year range
1.
Ying Yong Sheng Tai Xue Bao ; 31(8): 2785-2792, 2020 Aug.
Article in Chinese | MEDLINE | ID: mdl-34494802

ABSTRACT

To investigate the swimming ability of two Schizothorax species in the Yalung River and provide basic parameters for the studies on fish behavior and the design of fish passage, we exa-mined the induced velocity, critical swimming speed, and burst swimming speed in Schizothorax dolichonema and Schizothorax prenanti with incremental velocity method and the durable swimming speed in S. dolichonema with fixed velocity method. The results showed that the induced velocity of both species increased first and then plateaued with the increases of body length, with the maximum values being lower than 0.2 m·s-1. The critical swimming speed and burst swimming speed of S. dolichonema were (0.81±0.20) and (1.49±0.26) m·s-1, respectively, while the relative critical swimming speed and the relative burst swimming speed were (4.90±1.73) and (9.77±1.72) BL·s-1 (BL: body length), respectively. For S. prenanti, the critical swimming speed and burst swimming speed were (0.73±0.24) and (1.17±0.39) m·s-1, respectively, while the relative critical swimming speed was (6.88±2.82) BL·s-1, and the relative burst swimming speed was (11.75±2.77) BL·s-1. The swimming duration of S. dolichonema was negatively correlated with the flow velocity of 0.7-1.5 m·s-1, and the relationship between fatigue time (T) and flow velocity (V) was fitted into lgT=-2.52V+5.59. The relationship between expected fishway length (d) and the tolerable maximum average flow velocity (Vf max) was accordingly derived to be Vf max=-0.17lnd+1.74. Taken together, the fishway targeting S. dolichonema and S. prenanti was recommended to generate the in-channel velocity larger than 0.2 m·s-1, while the velocity at the entrance and verticle slot should be 0.73-1.67 m·s-1, and the main-flow velocity in rest pools should be 0.2-0.7 m·s-1.


Subject(s)
Cyprinidae , Swimming , Animals , China , Rivers
2.
J Neurosci ; 33(21): 9028-38, 2013 May 22.
Article in English | MEDLINE | ID: mdl-23699514

ABSTRACT

Patients with long-standing diabetes frequently demonstrate gastric hypersensitivity with an unknown mechanism. The present study was designed to investigate roles for nuclear factor-κB (NF-κB) and the endogenous H2S-producing enzyme cystathionine-ß-synthetase (CBS) signaling pathways by examining cbs gene methylation status in adult rats with diabetes. Intraperitoneal injection of streptozotocin (STZ) produced gastric hypersensitivity in female rats in response to gastric balloon distention. Treatment with the CBS inhibitor aminooxyacetic acid significantly attenuated STZ-induced gastric hypersensitivity in a dose-dependent fashion. Aminooxyacetic acid treatment also reversed hyperexcitability of gastric-specific dorsal root ganglion (DRG) neurons labeled by the dye DiI in diabetic rats. Conversely, the H2S donor NaHS enhanced neuronal excitability of gastric DRG neurons. Expression of CBS and p65 were markedly enhanced in gastric DRGs in diabetic rats. Blockade of NF-κB signaling using pyrrolidine dithiocarbamate reversed the upregulation of CBS expression. Interestingly, STZ treatment led to a significant demethylation of CpG islands in the cbs gene promoter region, as determined by methylation-specific PCR and bisulfite sequencing. STZ treatment also remarkably downregulated the expression of DNA methyltransferase 3a and 3b. More importantly, STZ treatment significantly enhanced the ability of cbs to bind DNA at the p65 consensus site, as shown by chromatin immunoprecipitation assays. Our findings suggest that upregulation of cbs expression is attributed to cbs promoter DNA demethylation and p65 activation and that the enhanced interaction of the cbs gene and p65 contributes to gastric hypersensitivity in diabetes. This finding may guide the development and evaluation of new treatment modalities for patients with diabetic gastric hypersensitivity.


Subject(s)
Cystathionine beta-Synthase/metabolism , Diabetes Mellitus, Experimental/complications , Hypersensitivity , NF-kappa B/metabolism , Stomach Diseases/etiology , Amino Acids , Analysis of Variance , Animals , Area Under Curve , Case-Control Studies , Chromatin Immunoprecipitation , CpG Islands/drug effects , CpG Islands/physiology , Cystathionine beta-Synthase/genetics , DNA (Cytosine-5-)-Methyltransferases/genetics , DNA (Cytosine-5-)-Methyltransferases/metabolism , DNA Methyltransferase 3A , Disease Models, Animal , Dose-Response Relationship, Drug , Electromyography , Enzyme Inhibitors/pharmacology , Female , Ganglia, Spinal/pathology , Hypersensitivity/drug therapy , Hypersensitivity/etiology , Membrane Potentials/drug effects , Methylation/drug effects , Neoplasm Proteins/metabolism , Nucleocytoplasmic Transport Proteins/metabolism , Oxamic Acid/therapeutic use , Patch-Clamp Techniques , Rats , Rats, Sprague-Dawley , Sensory Receptor Cells/drug effects , Sensory Receptor Cells/physiology , Stomach Diseases/drug therapy , Sulfites/pharmacology , Up-Regulation/drug effects , DNA Methyltransferase 3B
SELECTION OF CITATIONS
SEARCH DETAIL
...